These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 12531340)

  • 1. Impact of universal vaccination programmes on the epidemiology of hepatitis B: 10 years of experience in Italy.
    Bonanni P; Pesavento G; Bechini A; Tiscione E; Mannelli F; Benucci C; Nostro AL
    Vaccine; 2003 Jan; 21(7-8):685-91. PubMed ID: 12531340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term epidemiological survey of hepatitis B virus infection in a hyperendemic area (Afragola, southern Italy): results of a pilot vaccination project.
    Da Villa G; Piccinino F; Scolastico C; Fusco M; Piccinino R; Sepe A
    Res Virol; 1998; 149(5):263-70. PubMed ID: 9879603
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of routine infant and adolescent hepatitis B vaccination in Tuscany, Central Italy.
    Bonanni P; Colombai R; Gasparini R; Lo Nostro A; Tiscione E; Tomei A; Montomoli E; Comodo N
    Pediatr Infect Dis J; 1999 Aug; 18(8):677-82. PubMed ID: 10462335
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sero-epidemiology of hepatitis B markers in the population of Tuscany, Central Italy, 20 years after the implementation of universal vaccination.
    Boccalini S; Pellegrino E; Tiscione E; Pesavento G; Bechini A; Levi M; Rapi S; Mercurio S; Mannelli F; Peruzzi M; Berardi C; Bonanni P
    Hum Vaccin Immunother; 2013 Mar; 9(3):636-41. PubMed ID: 23354158
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute hepatitis B 14 years after the implementation of universal vaccination in Italy: areas of improvement and emerging challenges.
    Mele A; Tosti ME; Mariano A; Pizzuti R; Ferro A; Borrini B; Zotti C; Lopalco P; Curtale F; Balocchini E; Spada E;
    Clin Infect Dis; 2008 Mar; 46(6):868-75. PubMed ID: 18269332
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Universal hepatitis B immunization: infant, and infant plus adolescent immunization.
    Bonanni P
    Vaccine; 1998 Nov; 16 Suppl():S17-22. PubMed ID: 9915027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Implementation in Italy of a universal vaccination programme against hepatitis B.
    Bonanni P
    Vaccine; 1995; 13 Suppl 1():S68-71. PubMed ID: 7571837
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis B in Italy: where we are ten years after the introduction of mass vaccination.
    Mele A; Stroffolini T; Zanetti AR
    J Med Virol; 2002 Jul; 67(3):440-3. PubMed ID: 12116041
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis B vaccination in children: the Taiwan experience.
    Ni YH; Chen DS
    Pathol Biol (Paris); 2010 Aug; 58(4):296-300. PubMed ID: 20116181
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis B vaccination: universal vaccination of newborn babies and children at 12 years of age versus high risk groups. A comparison in the field.
    Da Villa G; Picciottoc L; Elia S; Peluso F; Montanaro F; Maisto T
    Vaccine; 1995 Sep; 13(13):1240-3. PubMed ID: 8578810
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A mathematical model of hepatitis B virus transmission and its application for vaccination strategy in china.
    Zhao S; Xu Z; Lu Y
    Int J Epidemiol; 2000 Aug; 29(4):744-52. PubMed ID: 10922354
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Success stories in the implementation of universal hepatitis B vaccination: an update on Italy.
    Bonanni P; Crovari P
    Vaccine; 1998 Nov; 16 Suppl():S38-42. PubMed ID: 9915032
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is hepatitis B vaccination performed at infant and adolescent age able to provide long-term immunological memory? An observational study on healthcare students and workers in Florence, Italy.
    Bini C; Grazzini M; Chellini M; Mucci N; Arcangeli G; Tiscione E; Bonanni P
    Hum Vaccin Immunother; 2018 Feb; 14(2):450-455. PubMed ID: 29106317
    [TBL] [Abstract][Full Text] [Related]  

  • 14. From hepatitis B to hepatitis A and B prevention: the Puglia (Italy) experience.
    Germinario C; Lopalco PL; Chirona M; Da Villa G
    Vaccine; 2000 Feb; 18 Suppl 1():S83-5. PubMed ID: 10683558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute Hepatitis B After the Implementation of Universal Vaccination in Italy: Results From 22 Years of Surveillance (1993-2014).
    Tosti ME; Alfonsi V; Lacorte E; Mele A; Galli C; Zanetti AR; Romanò L;
    Clin Infect Dis; 2016 Jun; 62(11):1412-8. PubMed ID: 27009250
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of hepatitis B vaccination in a highly endemic area of south Italy and long-term duration of anti-HBs antibody in two cohorts of vaccinated individuals.
    Da Villa G; Romanò L; Sepe A; Iorio R; Paribello N; Zappa A; Zanetti AR
    Vaccine; 2007 Apr; 25(16):3133-6. PubMed ID: 17280750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The worldwide impact of vaccination on the control and protection of viral hepatitis B.
    Romano' L; Paladini S; Van Damme P; Zanetti AR
    Dig Liver Dis; 2011 Jan; 43 Suppl 1():S2-7. PubMed ID: 21195368
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rationale for the infant and adolescent vaccination programmes in Italy.
    Da Villa G
    Vaccine; 2000 Feb; 18 Suppl 1():S31-4. PubMed ID: 10683541
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Successful mass vaccination against hepatitis B virus in a hyperendemic area in Italy.
    Da Villa G
    Res Virol; 1993; 144(4):255-8. PubMed ID: 8210705
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The epidemiological characteristics of HBV susceptibility in 1-29 years old young people in China in 2006 and 2014: based on the national sero-survey data analysis].
    Zheng H; Wang FZ; Zhang GM; Miao N; Sun XJ; Cui FQ
    Zhonghua Yu Fang Yi Xue Za Zhi; 2017 Jul; 51(7):581-586. PubMed ID: 28693080
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.